HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CARB

This article was originally published in The Rose Sheet

Executive Summary

Consumer Products Regulation Workgroup will hold its fourth meeting on consumer products regulations that will be presented to the California Air Resources Board in November on July 25 in Sacramento, Calif., CARB reports July 6. Workgroup plans to discuss the 2006 consumer products regulation amendments, specifically "draft regulatory category definitions with modified proposed volatile organic compound limits and other regulatory changes." At the workgroup's third meeting in June, the group discussed an initial draft list of VOC limits for various categories of products; the list was subject to revisions based on input from industry and stakeholders (1"The Rose Sheet" June 5, 2006. p. 7)...

You may also be interested in...



VOC Reactivity Standards For Hair Spray Weighed During CARB Meeting

A California Air Resources Board proposal to set a limit on the reactivity of volatile organic compounds in hair spray in addition to the existing mass-based VOC limit was debated during a June 1 Consumer Products Regulation Workgroup Meeting

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel